Reference : Imaging of large vessel vasculitis with (18)FDG PET: illusion or reality? A critical ...
Scientific journals : Letter to the editor
Human health sciences : Radiology, nuclear medicine & imaging
Imaging of large vessel vasculitis with (18)FDG PET: illusion or reality? A critical review of the literature data
Belhocine, Tarik [> > > >]
Blockmans, Daniel [> > > >]
Hustinx, Roland mailto [Université de Liège - ULiège > Département des sciences cliniques > Médecine nucléaire]
Vandevivere, Johan [> > > >]
Mortelmans, Luc [> > > >]
European Journal of Nuclear Medicine and Molecular Imaging
Yes (verified by ORBi)
New York
[en] large vessel vasculitides ; Takayasu arteritis ; giant cell arteritis ; FDG PET
[en] Fluorine-18 fluorodeoxyglucose positron emission tomography ((18)FDG PET) plays a major role in the management of oncology patients. Owing to the singular properties of the glucose tracer, many patients suffering from non-malignant diseases such as inflammatory or infectious diseases may also derive clinical benefit from the appropriate use of metabolic imaging. Large vessel vasculitides such as giant cell arteritis and Takayasu arteritis are other examples that may potentially extend the field of (18)FDG PET indications. The purpose of the present article is to assess the feasibility of metabolic imaging in vasculitis on the basis of the current literature data. In particular, the clinical context and the (18)FDG imaging patterns seen in patients with large vessel vasculitis are analysed in order to identify potential indications for metabolic imaging.

File(s) associated to this reference

Fulltext file(s):

Restricted access
Belhocine et al, EJNMMI 2003.pdfNo commentaryPublisher postprint313.55 kBRequest copy

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.